Akebia Therapeutics’ $50 Million Common Stock Offering

Latham & Watkins advised the underwriters in the offering, and Wilmer Cutler Pickering Hale and Dorr represented Akebia Therapeutics, Inc. Proskauer Rose advised Akebia Therapeutics, Inc….

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here